- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01324765
Women Overcoming and Managing Adversity Now (WOMAN) Study (WOMAN)
March 28, 2011 updated by: UConn Health
The goal of the study is to evaluate the efficacy of a two therapeutic models designed to enhance women's skills for managing reactive emotions in their current lives as well as to educate them about how using these skills can enhance their personal effectiveness and help them to gain control of post-traumatic stress reactions.
The interventions adaptations of a manualized psychotherapy that has shown promise with adults with complex Posttraumatic Stress Disorder (PTSD) (Trauma Affect Regulation: Guide for Education and Therapy; TARGET) compared to a supportive group therapy (SGT) that has been found to have modest benefits with women survivors of childhood abuse (Wallis, 2002).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In a randomized treatment design, we will compare offenders receiving skills-based intervention (TARGET) and those receiving a similar amount of supportive intervention (SGT).
We will assess the efficacy of treatment by determining if those receiving the TARGET skills training show an improvement in functionality, as compared to those receiving only supportive intervention.
We will measure this by analyzing PTSD symptoms, psychological distress, psychosocial functioning, and social/legal adjustment and services using structured interviews, self-report questionnaires and qualitative questions.
Questionnaires are listed below in the outcome measure's section.
We will collect follow-up data on program participants who successfully finish the program at York.
For those offenders who discharge into the community directly from York, we will collect follow-up data on program participants through CDOC Parole or Probation records.
Statistically we anticipate a medium effect size difference between the treatment conditions.
Study Type
Interventional
Enrollment (Actual)
108
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
Niantic, Connecticut, United States, 06357
- York Correctional Institution
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Incarcerated, release not expected within 6 months
- Probable PTSD on PC-PTSD screen and PTSD by CAPS interview
Exclusion Criteria
- Clinically significant psychopathy (PCL-SV severe range)
- Unable to comprehend study materials (Mini-Mental Status Exam Orientation, Attention, and Recall sections total score <15).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TARGET
12-session affect regulation therapy for PTSD
|
12-session group therapy twice weekly 6 weeks
|
Active Comparator: SGT
12 session supportive group therapy
|
12 sessions supportive group therapy twice weekly 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PTSD
Time Frame: Post-therapy (within 2 weeks)
|
PTSD symptom severity, Clinician Administered PTSD Scale
|
Post-therapy (within 2 weeks)
|
PTSD
Time Frame: 3-4 Month Post-therapy Follow-up
|
PTSD symptom severity, Clinician Administered PTSD Scale
|
3-4 Month Post-therapy Follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Emotion Regulation
Time Frame: Post-therapy (within 2 weeks)
|
Negative Mood Regulation Scale
|
Post-therapy (within 2 weeks)
|
Trauma-related symptoms
Time Frame: Post-therapy (within 2 weeks)
|
Trauma Symptom Inventory (TSI; Briere, 1995).
The TSI is a reliable and validated 100-item measure that generates composite scores for trauma (PTSD symptoms), self (self-regulation problems), and dysphoria (depression, anxiety, anger symptoms).
|
Post-therapy (within 2 weeks)
|
Mental health symptoms, well-being, and self-harm
Time Frame: Post-therapy (within 2 weeks)
|
CORE-OM is a 34-item self-report measure reliably and validly assessing current psychiatric symptom severity, risk of harm to self or others, social functioning, and subjective well being
|
Post-therapy (within 2 weeks)
|
Emotion Regulation
Time Frame: 3-4 Month Post-therapy Follow-up
|
Negative Mood Regulation Scale
|
3-4 Month Post-therapy Follow-up
|
Trauma-related Symptoms
Time Frame: 3-4 Month Post-therapy Follow-up
|
Trauma Symptom Inventory
|
3-4 Month Post-therapy Follow-up
|
Mental health symptoms, well-being, and self-harm
Time Frame: 3-4 Month Post-therapy Follow-up
|
CORE-OM 34-item questionnaire
|
3-4 Month Post-therapy Follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Julian D Ford, Ph.D., Uconn Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (Actual)
November 1, 2010
Study Completion (Actual)
November 1, 2010
Study Registration Dates
First Submitted
September 23, 2010
First Submitted That Met QC Criteria
March 28, 2011
First Posted (Estimate)
March 29, 2011
Study Record Updates
Last Update Posted (Estimate)
March 29, 2011
Last Update Submitted That Met QC Criteria
March 28, 2011
Last Verified
March 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09009-2
- 2009-DD-BX-0003 (Other Grant/Funding Number: Department of Justice)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruiting
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Active, not recruiting
-
Oregon Health and Science UniversityEnrolling by invitation
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentPortland VA Medical CenterActive, not recruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
Clinical Trials on TARGET
-
Vanderbilt University Medical CenterCompleted
-
Mercy Health OhioStryker NeurovascularUnknown
-
The University of QueenslandNational Health and Medical Research Council, Australia; Cambridge University... and other collaboratorsRecruitingKidney Failure, Chronic | HyperphosphatemiaCanada, United Kingdom, Australia, Brazil, New Zealand
-
Great Ormond Street Hospital for Children NHS Foundation...University College, London; University of Southampton; University Hospital Southampton... and other collaboratorsCompletedHypoxia | Pediatric ALL | Critical CareUnited Kingdom
-
UConn HealthUniversity of PennsylvaniaCompletedAnger | Aggression | PTSDUnited States
-
Niklas NielsenLund University; The George Institute for Global Health, Australia; Copenhagen... and other collaboratorsCompletedOut-of-hospital Cardiac ArrestSweden, Netherlands, Norway, United Kingdom, Italy, Australia, Switzerland, Luxembourg, Czech Republic, Denmark
-
University Hospital Inselspital, BerneBrigham and Women's Hospital; Swiss National Science Foundation; University of...CompletedPatient ReadmissionSwitzerland
-
Sint MaartenskliniekRecruiting
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
NYU Langone HealthNational Institute of Mental Health (NIMH)WithdrawnStress Disorders, Post-Traumatic